Last quarter (Q4 2023), Poseida Therapeutics's total revenue was $25.00M, an increase of 148.68% from the same quarter last year. In Q4, Poseida Therapeutics's net income was $-25.35M. See Poseida Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 64.70M	$ 64.70M	$ 130.49M	$ 31.24M	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 64.70M	$ 64.70M	$ 130.49M	$ 31.24M	-	-
Operating Expense	$ 194.21M	$ 194.21M	$ 190.44M	$ 172.65M	$ 126.55M	$ 78.85M
Operating Income	$ -129.50M	$ -129.50M	$ -59.95M	$ -141.41M	$ -126.55M	$ -78.85M
Net Non Operating Interest Income Expense	$ -8.67M	$ -8.67M	$ -6.37M	$ -3.36M	$ -3.51M	$ -3.55M
Other Income Expense	$ -14.85M	$ -14.85M	$ -2.86M	$ -19.80M	$ 280.00K	$ -4.12M
Pretax Income	$ -123.32M	$ -123.32M	$ -63.46M	$ -124.97M	$ -129.78M	$ -86.53M
Tax Provision	$ 107.00K	$ 107.00K	$ 544.00K	$ -7.58M	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -123.43M	$ -123.43M	$ -64.00M	$ -124.97M	$ -129.78M	$ -86.53M
Basic EPS	$ -1.38	$ -1.37	$ -0.89	$ -2.01	$ -3.61	$ -2.41
Diluted EPS	$ -1.38	$ -1.37	$ -0.89	$ -2.01	$ -3.61	$ -2.41
Basic Average Shares	$ 360.74M	$ 90.19M	$ 71.95M	$ 62.24M	$ 36.00M	$ 35.93M
Diluted Average Shares	$ 360.74M	$ 90.19M	$ 71.95M	$ 62.24M	$ 36.00M	$ 35.93M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 194.21M	$ 194.21M	$ 190.44M	$ 172.65M	$ 126.55M	$ 78.85M
Net Income From Continuing And Discontinued Operation	$ -123.43M	$ -123.43M	$ -64.00M	$ -124.97M	$ -129.78M	$ -86.53M
Normalized Income	$ -45.05M	$ -97.43M	$ -50.13M	-	$ -129.78M	$ -79.84M
Interest Expense	-	-	-	-	$ 3.51M	$ 3.55M
EBIT	$ -114.65M	$ -114.65M	$ -57.09M	$ -121.62M	$ -126.27M	$ -82.97M
EBITDA	$ -86.93M	$ -116.63M	$ -52.82M	$ -116.24M	$ -123.68M	$ -81.78M

Currency in USD

Poseida Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing